Preferences of Dermato-oncologists for Adjuvant Therapy in Stage II Melanoma: A Nationwide Discrete Choice Experiment

Adjuvant treatment decisions in stage IIB/C melanoma require careful weighing of benefits and risks. Our aim was to investigate how dermato-oncologists in Germany prioritize efficacy, toxicity, and application mode of modern adjuvants in these stages. In a nationwide discrete choice experiment physi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Amelie Kraaz, Wiebke K. Peitsch, Laura Ratusznik, Katharina Diehl, Christian Kromer, Dilan Akbarzadeh, Marthe-Lisa Schaarschmidt, Juliane Weilandt
Format: Artigo
Jezik:Inglês
Izdano: Medical Journals Sweden 2025-09-01
Serija:Acta Dermato-Venereologica
Teme:
conjoint analysis
immune checkpoint inhibitors
melanoma
treatment preferences
targeted therapy
Online pristup:https://medicaljournalssweden.se/actadv/article/view/44135
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items